Larimar Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Larimar Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Larimar Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $3.21M, a 24.6% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $3.21M +$635K +24.6% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.92M +$201K +7.39% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $3.08M +$220K +7.7% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $2.9M -$99K -3.3% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.58M -$556K -17.7% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $2.72M -$551K -16.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $2.86M -$548K -16.1% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $3M -$543K -15.3% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $3.13M -$539K -14.7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $3.27M -$535K -14.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $3.41M -$530K -13.5% Dec 31, 2021 10-K 2023-03-14
Q3 2021 $3.54M -$554K -13.5% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $3.67M -$579K -13.6% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $3.81M -$3.12M -45.1% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $3.94M +$3.85M +4424% Dec 31, 2020 10-K 2022-03-25
Q3 2020 $4.09M -$3.08M -42.9% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $4.25M -$3.09M -42.1% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $6.93M +$6.05M +685% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $87K Dec 31, 2019 10-K 2021-03-04
Q3 2019 $7.17M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $7.34M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $883K Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.